🔮 OOTWOracle · All predictions · Odds sheet · Track record · How it works · Benchmark
Answers: Will psilocybin be FDA-approved? · Will MDMA be approved? · When will psychedelics be legal?

The ibogaine fast-track will draw a critical investigative piece questioning cardiac safety or political motives (MAHA angle) in a major outlet before 2026-09-15.

Predicted 2026-07-25 · Resolves 2026-09-15 · cultural · Global
70%
ORACLE CONFIDENCE
⏳ Pending
Every outcome is scored publicly in the ledger.

Ibogaine, a powerful psychedelic being fast-tracked by US drug regulators for veteran treatment, has a known risk of causing dangerous heart rhythm problems. A major newspaper or magazine is likely to publish a deep investigation asking whether the political push to approve it is moving too fast and putting people at risk. This matters because fast-tracking a drug with cardiac risks — especially under political pressure — could affect patient safety and public trust.

Resolution rule: YES if, by 2026-09-15, a major outlet (NYT, WaPo, WSJ, STAT News, Reuters, Bloomberg, The Atlantic, or equivalent) publishes an investigative/critical article on the ibogaine fast-track focused on cardiac safety or political/MAHA motives. Verified via the outlet's website. Checked 2026-09-15. NO otherwise.

Fast-track + Trump/MAHA framing + a psychoactive drug with known cardiac risk is an irresistible editorial target. Near-term and cleanly verifiable against named outlets.

5 new falsifiable predictions, every day at 12:05 PM ET.
Get tomorrow's Oracle →
Marketing byAN
Sacred 5-MeO-DMT Ceremonies · Miami
The Oldest Prayer, Remembered

Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.

Join the Free Weekly Circle →